Logo image
Sign in
An economic analysis of intravenous carboplatin plus dose-dense weekly paclitaxel versus intravenous carboplatin plus every three-weeks paclitaxel in the upfront treatment of ovarian cancer
Journal article   Peer reviewed

An economic analysis of intravenous carboplatin plus dose-dense weekly paclitaxel versus intravenous carboplatin plus every three-weeks paclitaxel in the upfront treatment of ovarian cancer

H. Dalton, X. Yu, L. Hu, B. Monk, I. Benjamin and J. Chan
Gynecologic oncology, Vol.120, pp.S13-S13
03/01/2011

Metrics

4 Record Views

Details